New ETF Launches for China Bond Market Access
Van Eck Global is rolling out a new exchange traded fund that allows U.S. investors access to the Chinese onshore bond market.
Van Eck Global is rolling out a new exchange traded fund that allows U.S. investors access to the Chinese onshore bond market.
The opening day the Zhuhai Air Show saw little action from the world's two leading commercial aircraft manufacturers.
International Market Centers Inc. has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.
The two key exchange traded funds that 24/7 Wall St. tracks for the evaluation of buybacks are the PowerShares Buyback Achievers ETF and the AdvisorShares TrimTabs Float Shrink ETF.
Cheniere Energy Tuesday the sale of two unsecured convertible payable-in-kind (PIK) notes to help fund a Corpus Christi natural gas liquefaction project.
Sprouts Farmers Market has announced that it will sell 15 million shares of its common stock held by affiliates of Apollo Global Management.
Alibaba founder Jack Ma said Tuesday in an interview that that Alipay will at some point come public on its own.
In a note to investors Tuesday morning, Oppenheimer analyst Holden Lewis commented on 3D Systems following its Monday earnings release.
Bloomin' Brands has filed with the SEC for a secondary offering, though potentially these shares may never hit the market in listed transactions.
On Tuesday, Standard & Poor's said it expects holiday sales to be below the historical average this year.
UBS is positive on the fourth-quarter prospects for regional local exchange carriers, citing increasing capital expenditures.
El Pollo Loco Holdings has filed with the U.S. Securities and Exchange Commission for a secondary offering of 6 million shares.
Oppenheimer's analyst Ella Ji has initiated coverage of Alibaba with an Outperform rating and a whopping $133 price target.
courtesy of XeroxAt its investor day presentation on Tuesday, Xerox Corp. (NYSE: XRX) is touting its strategy to deliver long-term value for shareholders “through earnings expansion, leading innovation and a diversified portfolio.” Fine, but…
A new report from Cowen makes the case that a blood test that detects evidence of cancer in the circulation could soon replace the older more traditional biopsy methods.